title: Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis.
abstract: Interleukin 1 (IL-1) may be a key mediator of inflammation and tissue damage in inflammatory bowel disease (IBD). In rabbits with immune complex-induced colitis, IL-1 alpha and beta mRNA levels were detectable at 4 h, peaked at 12 but were absent at 96 h after the induction of colitis. Colonic IL-1 tissue levels were measured by specific radioimmunoassays. IL-1 alpha was significantly elevated at 4 h (9.4 +/- 1.5 ng/g colon), progressively increased at 48 h (31 +/- 5.8 ng/g) and then decreased by 96 h (11.5 +/- 3.4 ng/g). IL-1 beta levels were 2.0 +/- 0.5 ng/g colon at 4 h, 5.0 +/- 1.6 ng/g at 48 h and undetectable by 96 h. By comparison, colonic levels of PGE2 and LTB4 were unchanged during the first 12 h and did not become elevated until 24 h. IL-1 alpha levels were highly correlated with inflammation (r = 0.885, P less than 0.0001), edema (r = 0.789, P less than 0.0001) and necrosis (r = 0.752, P less than 0.0005). Treatment with a specific IL-1 receptor antagonist (IL-1 ra) before and during the first 33 h after the administration of immune complexes markedly reduced inflammatory cell infiltration index (from 3.2 +/- 0.4 to 1.4 +/- 0.3, P less than 0.02), edema (from 2.2 +/- 0.4 to 0.6 +/- 0.3, P less than 0.01) and necrosis (from 43 +/- 10% to 6.6 +/- 3.2%, P less than 0.03) compared to vehicle-matched colitis animals. These studies demonstrate that (a) IL-1 gene expression and synthesis occur early in the course of immune complex-induced colitis; (b) are significantly elevated for 12 h before the appearance of PGE2 and LTB4; (c) tissue levels of IL-1 correlate with the degree of tissue inflammation and; (d) specific blockade of IL-1 receptors reduces the inflammatory responses associated with experimental colitis.
authors.affiliation: Department of Medicine, Harbor-University of California, Los Angeles Medical Center, Torrance 90502.
authors.forename: F
authors.initials: F
authors.lastname: Cominelli
authors.forename: C C
authors.initials: CC
authors.lastname: Nast
authors.forename: B D
authors.initials: BD
authors.lastname: Clark
authors.forename: R
authors.initials: R
authors.lastname: Schindler
authors.forename: R
authors.initials: R
authors.lastname: Lierena
authors.forename: V E
authors.initials: VE
authors.lastname: Eysselein
authors.forename: R C
authors.initials: RC
authors.lastname: Thompson
authors.forename: C A
authors.initials: CA
authors.lastname: Dinarello
mesh_terms: D000936:Antigen-Antibody Complex; D015152:Blotting, Northern; D003092:Colitis / Q000473:pathology / Q000503:physiopathology*; D004487:Edema; D015870:Gene Expression; D007375:Interleukin-1 / Q000235:genetics* / Q000378:metabolism; D007975:Leukotriene B4 / Q000096:biosynthesis; D009336:Necrosis; D011458:Prostaglandins E / Q000096:biosynthesis; D011971:Receptors, Immunologic / Q000037:antagonists & inhibitors / Q000502:physiology*; D017472:Receptors, Interleukin-1; D013997:Time Factors
chemical_list: D000936:Antigen-Antibody Complex; D007375:Interleukin-1; D011458:Prostaglandins E; D011971:Receptors, Immunologic; D017472:Receptors, Interleukin-1; D007975:Leukotriene B4